Coxsackie B1 Nosode, Coxsackie B3 Nosode, Coxsackie B4 Nosode, Coxsackie B5 Nosode
Generic Name: coxsackie b1 nosode, coxsackie b3 nosode, coxsackie b4 nosode, coxsackie b5 nosode
Dosage form: LIQUID. Active ingredients: HUMAN COXSACKIEVIRUS B1 (1 [hp_M]/mL); HUMAN COXSACKIEVIRUS B3 (1 [hp_M]/mL); HUMAN COXSACKIEVIRUS B4 (1 [hp_M]/mL); HUMAN COXSACKIEVIRUS B5 (1 [hp_M]/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: HUMAN COXSACKIEVIRUS B1 (1 [hp_M]/mL); HUMAN COXSACKIEVIRUS B3 (1 [hp_M]/mL); HUMAN COXSACKIEVIRUS B4 (1 [hp_M]/mL); HUMAN COXSACKIEVIRUS B5 (1 [hp_M]/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Nepafenac
nepafenac
Nonsteroidal Anti-inflammatory Drug [EPC]
11 DESCRIPTION ILEVRO ® 0.3% is a sterile, topical, NSAID prodrug for ophthalmic use. Each mL of ILEVRO ® 0.3% contains 3 mg of nepafenac. Nepafenac is designated chemically as 2-amino-3-benzoylbenzeneacetamide with an empirical formula of C 15 H 14 N 2 O 2 . The structural formula of nepafenac is: Nepafenac is a yellow crystalline powder. The molecular weight of nepafenac is 254.28 g/mol. ILEVRO ® 0.3% is supplied as a sterile, aqueous suspension with a pH approximately of 6.8.
Valproic Acid
valproic acid
Anti-epileptic Agent [EPC]
11 DESCRIPTION Valproic acid is a carboxylic acid designated as 2-propylpentanoic acid. It is also known as dipropylacetic acid. Valproic acid has the following structure: Valproic acid (pKa 4.8) has a molecular weight of 144 and occurs as a colorless liquid with a characteristic odor. It is slightly soluble in water (1.3 mg/mL) and very soluble in organic solvents. Valproic Acid Capsules are antiepileptics for oral administration. Each soft gelatin capsule contains 250 mg valproic acid.
Cr-5667753 Leader Daily Moisturizer
cr-5667753 leader daily moisturizer
Purpose Skin Protectant
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.